Roadmap for Diagnosis and Control of Important Poultry Diseases - PowerPoint PPT Presentation

1 / 56
About This Presentation
Title:

Roadmap for Diagnosis and Control of Important Poultry Diseases

Description:

Roadmap for Diagnosis and Control of Important Poultry Diseases – PowerPoint PPT presentation

Number of Views:2044
Avg rating:3.0/5.0
Slides: 57
Provided by: drkat8
Category:

less

Transcript and Presenter's Notes

Title: Roadmap for Diagnosis and Control of Important Poultry Diseases


1
Roadmap for Diagnosis and Control of Important
Poultry Diseases
  • Dr. J.M.Kataria
  • Director
  • National Institute of Animal Health
  • Department of Animal Husbandry, Dairying and
    Fisheries
  • Ministry of Agriculture, Govt.of India

2
Indian Poultry Industry
  • Egg production -Ranked 4th
  • Contributes - Rs.29000 crores to GNP
  • Potential tool
  • - To fight poverty
  • - Malnutrition
  • - Unemployment
  • Comprises - Small large commercial farms
    Network of hatcheries
  • Supporting Allied industries
  • - Compound feed
  • - Equipments
  • - Machinery
  • - Pharma and Biologicals

3
  • Poultry Diseases can be classified as
  • Ever-existent Diseases.
  • E.g. Bacterial pathogens, ND etc.
  • 2. Emerging diseases.
  • E.g. CIA, ARV infections, IBH-HPS etc.
  • 3. Re-emerging Diseases.
  • E.g. IB, MD etc.
  • 4. Exotic Diseases.
  • E.g. AI

4
NEWCASTLE DISEASE
  • Highly contagious
  • Dreaded disease recorded through out the world
  • Virus belongs to family paramyxoviridae
  • Three pathotypes-velogenic, mesogenic and
    lentogenic
  • Over 250 species of birds are susceptible
  • Pathotyping of isolates from outbreaks is
    important
  • Fusion-gene is of prime importance associated
    with virulence
  • Virulent has two basic amino acid at the cleavage
    site
  • Low pathogenic has one basic amino acid

5
LESIONS OF RANIKHET DISEASE IN PIGEONS AND
GUINEA FOWL
Pigeons affected with NDV Showing characteristic
signs of Nervous lesions like torticollis.
Guinea fowl showing nervous Lesions like
lameness.
6
  • Diagnosis
  • PM lesions
  • Histopathology
  • Serological Tests ( HI, SNT, ELISA)
  • RT-PCR

7
RT-PCR
  • Diagnosis of all the three pathotypes and also
    for specific amplification and differentiation

8
Direct Quantitative Real Time RT-PCR Pathotyping
9
Infectious Bursal Disease
  • Severe immunosuppressive disease caused by IBD
    virus, a member of birnaviridae family
  • Two serotypes
  • Classical, very virulent and variant pathotypes
  • A region of interest is VP2 having hyper variable
    region

10
GROSS LESIONS OF IBD INFECTIONS IN CHICKENS
HAEMORRHAGES IN THIGH MUSCLE
HAEMORRHAGES IN BURSA
11
Infectious Bursal Disease (IBD)
12
  • Diagnosis
  • Signs lesions
  • Histopathology
  • AGID
  • Immunofluorescence test
  • VN test
  • ELISA
  • RT-PCR

13
RE analysis of IBDV
  • Differentiation of very virulent IBDV from
    classical and variant viruses

14
  • Control
  • Avoid immuno suppression
  • Role of MA
  • Intermediate strain vaccine
  • Inactivated vaccine in breeders
  • Thermostable vaccine

15
CHICKEN INFECTIOUS ANAEMIA Aplastic
anaemia Generalized lymphoid atrophy
Clinical disease Haemorrhages Increased
mortality (secondary complications)
Multifactorial Diseases
Key Haemorrhagic syndrome CIAV Aplastic
anaemia syndrome Role Gangrenous dermatitis
Blue wing disease Circular single stranded DNA
virus belonging to circoviridae family
16
GROSS LESIONS IN SPF CHICKS EXPERIMENTALLY
INFECTED WITH CIAV
1
2
3
4
5
A
B
  • A Normal organs of control chick (thymus,
  • longitudinal section of femur bones, bursa,
    spleen and liver) (12 days old) B
  • Severe atrophic thymus,
  • Longitudinal section of femur bones showing
    pale bone marrow,
  • Atrophic bursa,
  • Atrophic spleen and
  • Pale liver of CIAV infected chick (12 DPI)

'A A control chick showing normal sized thymus
(12 DPI) 'B CIAV infected chick showing
severe atrophy of thymus (12 DPI)
17
  • Diagnosis Control
  • Signs lesions
  • Histopathology
  • Virus isolation ( in MDCC-CU 147 )
  • Immunofluorescence test
  • immunofluorescence or immunoperoxidase
    staining
  • No effective vaccine

18
MAREKS DISEASE
  • Lymphomatous and neuropathic
  • Alphaherpesvirus
  • Characterized by pleomorphic lymphocytic
    infiltration, tumors and arteriosclerosis.
  • Though very virulent MD virus was reported in
    European countries but in India it has not yet
    been isolated from any infected flock.

19
DIAGNOSIS
  • Clinical signs
  • Histopathology
  • Virus isolation
  • Membrane immunofluorescent staining for MD tumor
    associated surface antigen
  • Positive immunohistochemical staining for pp 38
    antigen

20
CONTROL
  • live attenuated vaccines
  • Cell-associated or cell-free (lyopholised) live
    virus or HVT
  • Oil adjuvant whole cell preparations and
    especially gB expressing fowl pox and
    baculoviurses elicit protective immune responses.
  • A DNA vaccine containing the infectious BAC 20
    clone of serotype 1 MDV was tested.
  • In India -HTV (FC-126) or SB-1 or in combination
    of the both.
  • Unlike the European countries, Rispen strains not
    used in India .

21
Infectious Bronchitis
  • Characterized by severe respiratory symptoms
    reproductive disorder and nephritis
  • Variant- High mortality in young chicks so far
    20 IBV variants identified worldwide and the
    little are no cross protection
  • New IBV like viruses have been isolated from
    turkeys
  • Spike protein gene (S-1) is of prime importance
    having hypervariable region

22
  • Appearance of new variants
  • High rate of evolution
  • Genetic recombination
  • Insertions
  • Mutations
  • Exhibit antigenic drift
  • An accurate and rapid serotype determination is
    an important factor in controlling IBV

23
Avian Reovirus ARV- Double stranded RNA having
10 segmentsS-gene coding for ?-protein is of
prime interest
  • MANIFESTATIONS OF REOVIRUS
  • JOINT
  • Arthritis/tenosynovitis
  • Ruptured gastrocnemius tenders
  • Slipped tendon
  • RESPIRATORY TRACT INFECTION
  • Respiratory disease (Fahey Crawley 1954)
  • DIGESTIVE TRACT INFECTION
  • Osteoporosis
  • Cloacal pasting
  • Hepatitis
  • HEART INVOLVEMENT
  • Pericarditis
  • Hydropericardium
  • BURSAL ATROPHY

24
LESIONS OF CHICKENS AFFECTED WITH AVIAN REOVIRUS
Swollen foot pad and hock joint in infected chick
Reovirus infected chicks with stunted growth
25
Diagnosis Control
  • Signs lesions
  • Histopathology
  • Demonstration of Viral antigens
  • Serological test (AGPT, FAT, ELISA)
  • Live and Attenuated Vaccines
    available
  • No vaccination in India at Present

26
Avian Influenza
  • HPAI arises from LPAI viruses.
  • Mortality Morbidity very high.(100)
  • Multiple visceral organ failure.
  • Nearly 24 outbreaks till 2004 have been reported.
  • How to differentiate b/w HPAI LPAI ?
  • DEFINITION OF EU
  • An infection of poultry caused by an
    influenza A virus that has an intravenous
    pathogenicity index in 6-week-old chickens gt1.2 /
    Any infection with influenza A viruses of' H5 or
    H7 subtype for which nucleotide sequencing has
    demonstrated the presence of multiple basic amino
    acids at the cleavage site of the haemagglutinin.

27
Clinical Symptoms
  • Dependant on virulence of virus, species
    affected
  • and other environmental conditions
  • HPAI
  • Often no clinical signs other than sudden death
  • Possible signs of illness
  • Soft-shelled eggs
  • Depression
  • Cyanosis of wattle and combs
  • Diarrhea
  • Loss of appetite
  • Respiratory distress

28
Diagnosis
  • Signs lesions
  • Histopathology
  • Viral Isolation Demonstration (ECE)
  • Serological test (HI)
  • RT-PCR

29
  • Vaccination
  • Vaccine is a valuable tool in the control and
    elimination of avian influenza
  • Vaccine alone is unlikely to lead to a successful
    eradication however vaccination combined with
    stamping out and adequate surveillance will
    likely lead to eradication in less time.
  • Strategic vaccination in birds, if accompanied by
    appropriate surveillance will reduce the amount
    of virus excreted and lead to less viral exposure
    for humans
  • Vaccine, if used, must be produced in accordance
    with OIE guidelines
  • Inactivated vaccines are the commonly used
    vaccines throughout the world, at present.

30
AVIAN MYCOPLASMA
  • Caused by Mycoplasma gallisepticum (MG) and M.
    synoviae (MS).
  • C R D characterized by coryza, conjunctivitis,
    sneezing, and by sinusitis
  • loss of production and downgrading of meat-type
    birds, and loss of egg production

31
DIAGNOSIS
  • Serological Test
  • Isolation in media
  • Detection of their DNA
  • FAT
  • Immunoperoxidase tests

32
CONTROL
  • Both killed vaccines (bacteria) and live vaccines
    are currently in commercial use.
  • A temperature sensitive (ts) clone derived from
    Australian M. synoviae field isolate produced by
    chemical mutagenesis was tested as live vaccine.
  • Bio-security measures.

33
Molecular Biological Techniques in Disease
Diagnosis
  • RE analysis of whole genome or variable region
  • Polymerase Chain Reaction
  • Highly sensitive, quick and confirmative
  • Used to detect the virus from decomposed tissue
  • Diagnosis and differentiation
  • Nucleic acid hybridization
  • Types of probes
  • Hot
  • Cold- Non-hazardous, can be stored for longer
    duration
  • Detection and differentiation
  • In situ hybridization
  • Dot-blot
  • Riboprobes- for detection of RNA viruses

34
  • Nucleotide sequencing
  • Cycle sequencing by Sangers method
  • Maxim-Gilbert method
  • Molecular epidemiology
  • Evaluation of viruses
  • Differentiation of strains
  • Complete genome analysis

35
Vaccines for the Future
  • Genetically engineered bacteria viruses- holds
    great promise for revolutionizing health
    management of poultry.
  • Development of multivalent single dose vaccines.
  • Improvements in routes of administration to
    decrease stress and
  • increase immune effectiveness. Eg. Multivalent
    vaccines by oral or drinking water.
  • RNA viruses particularly IBDV and IBV change
    their epitopes.
  • Quick identification of such epitopes and develop
    vaccines.
  • Practicing in-ovo vaccination
  • Development of food-based vaccines.
  • Reduce the cost of vaccine production.
  • Vaccines for rural poultry.

36
IN-OVO VACCINATION
  • Chickens develop some immunologic maturity before
  • hatching.
  • Vaccination in 18-day day embryos
  • Vaccine virus deposited in amniotic fluid
  • Embryos acquired infection via the respiratory
    tract.
  • No-appreciable adverse effect on hatchability or
    weight gain.
  • ADVANTAGES
  • Delivery of a uniform dose of vaccine in eggs.
  • Reduced labour cost associated with post-hatch
    vaccination.
  • Early post hatch resistance to field outbreaks.

37
IN-OVO VACCINATION
  • Mareks Disease
  • Quite useful ability of embryos vaccinated chick,
    to resist an early post hatch challenge
  • Maternal antibody interfere with HVT vaccination
  • Infectious bursal disease
  • No B-cells immunologic tolerance
  • Moderate type vaccine viruses are pathogenic
  • Low virulence virus
  • - No detectable lesions or
  • - Transient lesion in BF
  • Newcastle Disease
  • - ND-B1 routinely used post hatch vaccination
  • - Lethal for embryos.
  • Chemical treatment reduced virulence for embryos.

38
VACCINES FOR VILLAGE CHICKENS
  • Village flocks require special vaccines
  • Transportation and storage without refrigerators
  • Thermostable vaccines
  • Individual application is impossible
  • Through feed and water
  • Extremely cheap
  • Small dose pack size
  • Test for vaccine evaluation
  • Local chickens
  • Challenge organisms of local origin

39
FOOD BASED VACCINES
  • Could be useful for commercial chickens
  • Spray on feed
  • Concentrate of vaccine coated pellet
  • Stresses associated with handling for
    vaccination,
  • spray vaccination.
  • Vaccine must be robust, capable of infecting
    through digestive tract.
  • All attenuated vaccines not suitable for food
    vaccines e.g. fowl pox

40
  • Roadmap for Control
  • 1. Surveillance of high risk diseases
  • Sero-monitoring
  • Molecular epidemiology
  • Isolation identification and characterization of
    etiological agents
  • Monitoring of diseases in other Avian species
  • Formation of data bank on important diseases
  • Link between state, SAUs, central, and private,
    laboratories with the referral laboratory
  • Immediate reporting of diseases to refer
    laboratory

41
  • 2. Use of uniform vaccination schedule
  • 3. Evaluation of the commercial vaccines from
  • market
  • Development of diagnostics for quick, precise
    diagnosis and evaluation of commercial
    diagnostics.
  • Restriction of immunosuppressive agents.
  • - Testing of poultry feeds for mycotoxins
  • - Immunosuppressive potential of vaccines.
  • 6. Implementation of strict Bio-security in farm
    and
  • hatchery level with facilities for
    incineration.

42
7. Quarantine measures to be strengthened. 8.
Restriction of poultry Trade in disease affected
areas. 9. Development of human resources
specialized in Avian diseases. 10. Initiation of
poultry disease eradication programme (E.g.
Ranikhet Disease)
43
  • Thank you for your kind attention

44
(No Transcript)
45
(No Transcript)
46
(No Transcript)
47
(No Transcript)
48
(No Transcript)
49
(No Transcript)
50
(No Transcript)
51
(No Transcript)
52
(No Transcript)
53
(No Transcript)
54
(No Transcript)
55
(No Transcript)
56
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com